Vivos Therapeutics (NASDAQ:VVOS) Navigates Strategic Shift Amidst Analyst Downgrade and Revenue Growth
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameVivos Therapeutics Inc
-
Registration countryUSA
-
IndustryMedical Devices
-
М/S&P/F
*** /*** /***









